Canagliflozin does not increase fracture risk in diabetes patients

Canagliflozin treatment does not increase the risk of fractures in type-2 diabetes patients, according to research published inAnnals of Internal Medicine.MedicalXpress

Source: Society for Endocrinology - January 2, 2019 Category: Endocrinology Source Type: news